Revenue

A Utah fintech just landed a massive credit line to disrupt the luxury auto market. Here's how its AI platform is changing the game for car collectors.

Boston-based Reclaim Health wins a top AI award for its platform that automatically finds and recovers millions in medical billing errors for employers and staff.

Hycroft Mining announces world-class drill results at its Nevada mine, but a $34M executive compensation package adds a complex layer to the discovery.

The blank-check firm's unit split offers investor flexibility, but what does it signal about its search for a merger in today's selective SPAC market?

North American furniture disruptor Cozey lands on Abbot Kinney, testing its pop-up-to-permanent model in a key market before a global push.

Nashville's Werk Insight lands on the Inc. Regionals list, showcasing how specialized B2B research is fueling the Southeast's impressive economic boom.

A Pennsylvania marketing firm and its clients land on prestigious growth lists, proving a specialized strategy in trade industries is a powerful formula.

Cannabis tech leader BLAZE has launched Herbie, an AI budtender designed to personalize online sales, boost ROI, and navigate complex regulations.

With a new dispensary and an exclusive pre-roll line, Terrabis deepens its vertical integration in Illinois’s competitive cannabis market ahead of 4/20.

How the United Rugby Championship cut streaming costs by 62% and grew revenue by 35% after ditching legacy tech for Eluvio's innovative Content Fabric.

Ornn AI's new price index on the Bloomberg Terminal aims to bring transparency and Wall Street rigor to the chaotic $4 trillion AI compute market.

New federal rules make buying fake reviews a costly crime. Businesses now face $50,000+ fines per violation and digital ruin from AI-powered crackdowns.

With FDA clearance, Zeto New Wave™ promises to slash EEG wait times and ease staff shortages, making critical brain health data more accessible.

VanEck's new VEFA fund uses analyst upgrades to pick international stocks, aiming to capture returns as global markets gain on the concentrated US.

After a period of limited availability, the Ellipsys Vascular Access System is set for a 2026 relaunch, promising a less invasive option for dialysis patients.

Lipocine's stock plummets after its PPD drug fails a Phase 3 trial, but a promising signal in a patient subset offers a narrow path forward.

The classic internet speed test is obsolete. A new standard, TR-471, is shifting focus to what matters: latency, jitter, and reliability under load.

As chronic disease costs soar, a new program from Health Coach Institute promises to professionalize wellness coaching with structured, systems-based training.

Global commodities giant Traxys finalizes its acquisition of Sweden's Carbomax, a move set to reshape the Nordic green steel market and bolster supply chains.

The full commercial launch of the Aeros Modular Stem System brings advanced 3D printing and a novel surgical approach to the competitive ankle replacement market.